Ackman: Canada Better Than U.S. For Activists

Oct 17 2014 | 7:04am ET

Pershing Square Capital Management chief William Ackman headed north of the border yesterday to laud Canada’s welcoming environment for activist hedge funds.

Ackman said that Canada’s is “a better regime in almost every measure” for activists than the U.S. He praised the country’s “sensible approach” during a panel discussion held by the Ontario Securities Commission in Toronto.

In particular, Ackman highlighted the fact that Canadian regulators allow activists to buy up to 10% of a company before having to disclose their move, compared to just 5% in the U.S. And he also credited Canada’s regulators for routinely removing poison pills after just a short period; in the U.S., poison pills can be effectively permanent bars against activist activity.

“The U.S. is gradually migrating on some of these issues to where Canada is,” Ackman said.

Not everything is easier for activists up north. Ackman said that it can be difficult “to recruit Canadians to serve on the board in a dissident proxy contest against the incumbents on the board.”

Ackman has been active in Canada, two years ago winning a proxy contest against Canadian Pacific Railways. He is also working with Québec’s Valeant Pharmaceuticals International on its hostile takeover bid for Allergan Inc.

Ackman declined to comment directly about Canadian Pacific’s recent approach to CSX Corp. about a takeover, saying simply that the company’s CEO has said “some consolidation can meaningfully address the congestion problems.” 

In Depth

PAAMCO: Will Inflation Deflate the Asset Bubble?

Jan 30 2018 | 9:49pm ET

As the U.S. shifts from monetary stimulus to fiscal stimulus, market pricing should...


CFA Institute To Add Computer Science To Exam Curriculum

May 24 2017 | 9:25pm ET

Starting in 2019, financial industry executives sitting for the coveted Chartered...

Guest Contributor

Boost Hedge Fund Marketing ROI By Raising Your ROO

Feb 14 2018 | 9:57pm ET

Tasked with delivering returns on client capital, a common dilemma for many alternative...